Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
about
Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial CellsLipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infectionCharacterization of Changes in Global Genes Expression in the Distal Colon of Loperamide-Induced Constipation SD Rats in Response to the Laxative Effects of Liriope platyphylla.Neutrophil gelatinase-associated lipocalin regulates gut microbiota of mice.Leukocyte-epithelial interactions and mucosal homeostasis.Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis.Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages.Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesisEffects of probiotics on Toll‑like receptor expression in ulcerative colitis rats induced by 2,4,6‑trinitro‑benzene sulfonic acid.Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.Transcriptional modulation of pattern recognition receptors in chronic colitis in mice is accompanied with Th1 and Th17 response.MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic mice.Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.SMAD4 Protein Expression Is Downregulated in Ileal Epithelial Cells from Patients with Crohn's Disease with Significant Inverse Correlation to Disease Activity.
P2860
Q28550697-DFDE87F0-63C2-4388-9411-6BA091B81A69Q34646648-D97BEF07-9721-4ABB-A190-C1D7DBE44DF2Q35685299-1034E6AC-4DBB-42CD-8042-DDA899400C51Q35696770-34B256B3-1506-4463-BBB3-4B0FF837B4D2Q35755835-F083B0B4-EBAA-4D88-8FEA-B2E0843E5B7BQ37119613-86AC2783-B041-49A8-A28B-A803260549DAQ37335648-AAB1B2E0-3B4F-4748-9BFE-1BDE4E9F5964Q37511583-250898F8-AB74-42AE-A24C-547D98129D26Q37720200-DE4D5B59-B053-4A88-A331-E21BB7195507Q39003418-39943C4D-3BD8-4DE0-B00E-A47B0712F95AQ40536632-B48C1804-2BF1-4429-814A-6B3AC34CA191Q41185159-5F09195B-17F3-4D07-80CE-C869058396AFQ41682028-49EB568E-21A3-48EA-8AE2-DAE9FC53544AQ41764233-04E0C539-B0C3-4FB0-937C-D9C78AB5E102Q48339147-A1114B81-679E-4C14-B644-AAE81EF98FF5Q55154729-90D46360-A528-404E-BA42-B8924AC4454EQ55428206-3E9F0CA0-BF17-420A-862E-8C2BB492A64F
P2860
Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Expression of Toll-like recept ...... essive release of lipocalin 2.
@en
Expression of Toll-like recept ...... essive release of lipocalin 2.
@nl
type
label
Expression of Toll-like recept ...... essive release of lipocalin 2.
@en
Expression of Toll-like recept ...... essive release of lipocalin 2.
@nl
prefLabel
Expression of Toll-like recept ...... essive release of lipocalin 2.
@en
Expression of Toll-like recept ...... essive release of lipocalin 2.
@nl
P2093
P2860
P356
P1476
Expression of Toll-like recept ...... essive release of lipocalin 2.
@en
P2093
A E Østvik
A Flatberg
A K Sandvik
A V B Granlund
H L Waldum
P2860
P304
P356
10.1111/CEI.12136
P577
2013-09-01T00:00:00Z